Home › Funds › Revelation Capital Management, LLC › ARTV
Revelation Capital Management, LLC position in ARTV
ARTIVA BIOTHERAPEUTICS INC · Health Care
Revelation Capital Management, LLC reported holding 299,311 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 26.60% of its reported portfolio and ranking #2 among its reported holdings. Revelation Capital Management, LLC has disclosed ARTV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-03 · Source: SEC EDGAR Form 13F-HR
How Revelation Capital Management, LLC's ARTV position evolved
Revelation Capital Management, LLC first disclosed a stake in ARTV in Q4 2025 at 299,311 shares (US$1.3M). The position peaked in Q2 2026 at 299,311 shares, worth US$2.9M. Across 4 filings, Revelation Capital Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 299,311 shares valued at US$2.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 299.31K | $1.28M | New |
| Q1 2026 | 299.31K | $1.93M | Hold |
| Q2 2026 | 299.31K | $2.90M | Hold |
| Q3 2026 | 299.31K | $2.13M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARTV and 13F data
ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 61 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$174.2M), 5AM Venture Management, LLC (US$22.8M), Venrock Adviser, LLC (US$19.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARTV
- RA CAPITAL MANAGEMENT, L.P. 17.96M sh · $174.17M · Q2 2026
- 5AM Venture Management, LLC 2.35M sh · $22.83M · Q2 2026
- Venrock Adviser, LLC 2.04M sh · $19.82M · Q2 2026
- Caligan Partners LP 1.74M sh · $16.84M · Q2 2026
- Samsara BioCapital, LLC 954.86K sh · $9.26M · Q2 2026
- Blue Owl Capital Holdings LP 874.54K sh · $8.48M · Q2 2026
- Propel Bio Management, LLC 696.44K sh · $6.76M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 525.00K sh · $5.09M · Q2 2026
- ACUTA CAPITAL PARTNERS, LLC 260.42K sh · $2.53M · Q2 2026
- KVP Capital Advisors, LP 200.00K sh · $1.94M · Q2 2026
- Velan Capital Investment Management LP 25.00K sh · $242.50K · Q2 2026
- Spark Investment Management LLC 16.50K sh · $160.05K · Q2 2026
More on Revelation Capital Management, LLC
FAQ
How long has Revelation Capital Management, LLC held ARTV?
Revelation Capital Management, LLC has disclosed ARTV holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Revelation Capital Management, LLC's current position in ARTV?
As of Q3 2026, Revelation Capital Management, LLC holds 299.31K shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $2.13M, representing 26.60% of its reported portfolio and ranking #2.
Has Revelation Capital Management, LLC been buying or selling ARTV?
In the latest 13F filing (Q3 2026), Revelation Capital Management, LLC held unchanged its position in ARTV. The position peaked in Q2 2026 at 299.31K shares.
Which other funds hold ARTV?
Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Venrock Adviser, LLC, among 61 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.